Biomerieux Valuation
| BIM Stock | EUR 98.85 0.20 0.20% |
At this time, the firm appears to be overvalued. Biomerieux SA shows a prevailing Real Value of €88.07 per share. The current price of the firm is €98.85. Our model approximates the value of Biomerieux SA from analyzing the firm fundamentals such as Profit Margin of 0.16 %, return on equity of 0.18, and Current Valuation of 11.4 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biomerieux's price fluctuation is very steady at this time. Calculation of the real value of Biomerieux SA is based on 3 months time horizon. Increasing Biomerieux's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biomerieux is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biomerieux Stock. However, Biomerieux's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 98.85 | Real 88.07 | Hype 99.05 |
The real value of Biomerieux Stock, also known as its intrinsic value, is the underlying worth of Biomerieux SA Company, which is reflected in its stock price. It is based on Biomerieux's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Biomerieux's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Biomerieux SA helps investors to forecast how Biomerieux stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomerieux more accurately as focusing exclusively on Biomerieux's fundamentals will not take into account other important factors: Biomerieux Total Value Analysis
Biomerieux SA is currently expected to have takeover price of 11.4 B with market capitalization of 11.04 B, debt of 362.8 M, and cash on hands of 280.1 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biomerieux fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.4 B | 11.04 B | 362.8 M | 280.1 M |
Biomerieux Investor Information
About 64.0% of the company shares are held by company insiders. The book value of Biomerieux was currently reported as 29.31. The company has Price/Earnings To Growth (PEG) ratio of 2.9. Biomerieux SA last dividend was issued on the 6th of June 2022. The entity had 3:1 split on the 20th of September 2017. Based on the key measurements obtained from Biomerieux's financial statements, Biomerieux SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Biomerieux Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biomerieux has an asset utilization ratio of 73.13 percent. This suggests that the Company is making €0.73 for each dollar of assets. An increasing asset utilization means that Biomerieux SA is more efficient with each dollar of assets it utilizes for everyday operations.Biomerieux Ownership Allocation
Biomerieux holds a total of 118.37 Million outstanding shares. Biomerieux SA shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.28 percent of Biomerieux SA outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biomerieux Profitability Analysis
The company reported the revenue of 3.38 B. Net Income was 601.1 M with profit before overhead, payroll, taxes, and interest of 1.96 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biomerieux's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biomerieux and how it compares across the competition.
About Biomerieux Valuation
The stock valuation mechanism determines Biomerieux's current worth on a weekly basis. Our valuation model uses a comparative analysis of Biomerieux. We calculate exposure to Biomerieux's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biomerieux's related companies.bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. BIOMERIEUX operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 11200 people.
8 Steps to conduct Biomerieux's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biomerieux's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biomerieux's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biomerieux's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biomerieux's revenue streams: Identify Biomerieux's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biomerieux's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biomerieux's growth potential: Evaluate Biomerieux's management, business model, and growth potential.
- Determine Biomerieux's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biomerieux's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Biomerieux Stock analysis
When running Biomerieux's price analysis, check to measure Biomerieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerieux is operating at the current time. Most of Biomerieux's value examination focuses on studying past and present price action to predict the probability of Biomerieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerieux's price. Additionally, you may evaluate how the addition of Biomerieux to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |